-
1
-
-
35848943277
-
Safety and tolerability of olopatadine 0.2% in children and adolescents
-
Lichtenstein SJ, Pasquine TA, Edwards MR, Wells DT, Gross RD, Robertson SM. Safety and tolerability of olopatadine 0.2% in children and adolescents. J Ocul Pharmacol Ther 2007;23:366-71.
-
(2007)
J Ocul Pharmacol Ther
, vol.23
, pp. 366-371
-
-
Lichtenstein, S.J.1
Pasquine, T.A.2
Edwards, M.R.3
Wells, D.T.4
Gross, R.D.5
Robertson, S.M.6
-
2
-
-
4544333095
-
A review of olopatadine for the treatment of ocular allergy
-
Abelson MB. A review of olopatadine for the treatment of ocular allergy. Exp Opin Pharmacother 2004;5:1979-94.
-
(2004)
Exp Opin Pharmacother
, vol.5
, pp. 1979-1994
-
-
Abelson, M.B.1
-
3
-
-
6344248682
-
Clinical efficacy of olopatadine hydrochloride ophthalmic solution 0.2% compared with placebo in patients with allergic conjunctivitis or rhinoconjunctivitis: A randomized, double-masked environmental study
-
Abelson MB, Gomes PJ, Vogelson CT, Pasquine TA, Gross RD, Turner FD, et al. Clinical efficacy of olopatadine hydrochloride ophthalmic solution 0.2% compared with placebo in patients with allergic conjunctivitis or rhinoconjunctivitis: A randomized, double-masked environmental study. Clin Ther 2004;26:1237-48.
-
(2004)
Clin Ther
, vol.26
, pp. 1237-1248
-
-
Abelson, M.B.1
Gomes, P.J.2
Vogelson, C.T.3
Pasquine, T.A.4
Gross, R.D.5
Turner, F.D.6
-
4
-
-
18744390020
-
A comparison of the efficacy and tolerability of olopatadine hydrochloride 0.1% ophthalmic solution and cromolyn sodium 2% ophthalmic solution in seasonal allergic conjunctivitis
-
Katelaris CH, Ciprandi G, Missotten L, Turner FD, Bertin D, Berdeaux G, et al. A comparison of the efficacy and tolerability of olopatadine hydrochloride 0.1% ophthalmic solution and cromolyn sodium 2% ophthalmic solution in seasonal allergic conjunctivitis. Clin Ther 2002;24:1561-75.
-
(2002)
Clin Ther
, vol.24
, pp. 1561-1575
-
-
Katelaris, C.H.1
Ciprandi, G.2
Missotten, L.3
Turner, F.D.4
Bertin, D.5
Berdeaux, G.6
-
5
-
-
0034869181
-
Evaluation of the efficacy of olopatadine hydrochloride 0.1% ophthalmic solution and azelastine hydrochloride 0.05% ophthalmic solution in the conjunctival allergen challenge model
-
Spangler DL, Bensch G, Berdy GJ. Evaluation of the efficacy of olopatadine hydrochloride 0.1% ophthalmic solution and azelastine hydrochloride 0.05% ophthalmic solution in the conjunctival allergen challenge model. Clin Ther 2001;23:1272-80.
-
(2001)
Clin Ther
, vol.23
, pp. 1272-1280
-
-
Spangler, D.L.1
Bensch, G.2
Berdy, G.J.3
-
6
-
-
0035723470
-
Post-inflammatory depigmentation following allergic contact dermatitis to chloroxylenol
-
Malakar S, Panda S. Post-inflammatory depigmentation following allergic contact dermatitis to chloroxylenol. Br J Dermatol 2001;144:1275-6.
-
(2001)
Br J Dermatol
, vol.144
, pp. 1275-1276
-
-
Malakar, S.1
Panda, S.2
-
7
-
-
0034755914
-
Hypopigmentation after non-permanent henna tattoo
-
Wohrl S, Hemmer W, Pocke M, Gotz M, Jarisch R. Hypopigmentation after non-permanent henna tattoo. J Eur Acad. Dermatol. Venereol 2001;15:470-2.
-
(2001)
J Eur Acad. Dermatol. Venereol
, vol.15
, pp. 470-472
-
-
Wohrl, S.1
Hemmer, W.2
Pocke, M.3
Gotz, M.4
Jarisch, R.5
|